Xcout Intel
IsomAb
IsomAb is a biotechnology research company headquartered in Nottingham, United Kingdom, focused on developing isoform-specific humanized antibodies to treat cardiovascular and other serious diseases.
Subscribe to see IsomAb’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
IsomAb at a glance
IsomAb is a biotechnology company headquartered in United Kingdom, founded in 2022. Its most recent funding round, Seed, raised $9.5M in February 2024.
IsomAb funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $9.5M | 3 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
IsomAb competitors
A few of IsomAb's closest competitors — see the full list of competitors and alternatives →
Alchemab Therapeutics Ltd is a biotechnology company headquartered in London, England, focused on pioneering patient-centric antibody discovery and development.
Adimab is a biotechnology research company headquartered in Lebanon, New Hampshire, that serves as a biopharmaceutical industry partner for therapeutic antibody discovery and engineering.
ProtAb Ltd is an Israeli biotechnology company headquartered in Jerusalem that develops therapeutic agents and antibodies to modulate cytokine regulation for the treatment of autoimmune and inflammatory diseases.
Numab Therapeutics is a Swiss biotechnology company developing multispecific antibody-based medicines that modulate immune-cell interactions. Its programs target serious diseases including cancer and immune-mediated or inflammatory disorders, serving patients through development and potential partnerships with pharmaceutical companies.
Get IsomAb's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on IsomAb in Xcout Intel
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access